Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients

Table 1 Baseline characteristics of the study patients

Variables	HF subjects (n=179)	Non-HF subjects (n=163)	p ^*
Age (years)^†	70 (58–76)	68 (57–75)	0.479
Gender (M/F)	132/47	123/40	0.716
Diabetes (%)	35	51	0.002
Hypertension (%)	57	71	0.010
Obesity (%)	41	44	0.807
Waist circumference (cm)	101.8±12.9	102.9±9.8	0.315
BMI (kg/m²)	29.0 (26.5−33.1)	29.3 (27.3−31.8)	0.975
SBP (mmHg)^†	120 (110–140)	137 (130–149)	< 0.001
DBP (mmHg)^†	70 (66–80)	85 (78–90)	< 0.001
Glucose (mmol/L)^†	5.9 (5.2–7.3)	6.2 (5.4–7.9)	0.386
Total-cholesterol (mmol/L)	4.72±1.29	5.03±1.11	0.028
LDL-cholesterol (mmol/L)	2.94±1.00	3.09±0.88	0.222
HDL-cholesterol (mmol/L)	1.11 (0.95–1.31)	1.34 (1.16–1.55)	< 0.001
Triglycerides (mmol/L)^†	1.35 (0.98–1.71)	1.50 (0.98–2.32)	0.008
FABP4 (μg/L)^†	29.1 (19.2−55.0)	24.2 (19.3−34.5)	< 0.001

Abbreviations: HF, heart failure; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, Low-Density Lipoprotein; HDL, High-Density Lipoprotein; FABP4, adipocyte fatty acid binding protein.
The data are presented as the mean±SD or median (interquartile range), unless otherwise indicated.
^*ANOVA and x² tests were used to compare the mean of quantitative variables or the frequency of qualitative traits between HF and non-HF groups of subjects.
^†Log-transformed before analysis.

ISSN: 1475-2840